en · de · es · fr · pt
bench-notes.peptides1126.com › Blog › Tesamorelin �ƒŒ景与作用机制 — Quick Reference

Tesamorelin �ƒŒ景与作用机制 — Quick Reference

By Editorial Desk · published 2025-11-20 · last reviewed 2026-01-11 · Blog

trans-3-hexenoyl is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-01-11. Numbers and descriptions here follow the published literature rather than marketing material.

tesamorelin 背景与作用机制

研究背景集中在特定人群的体成分改变,尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致,部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题,现有数据不足以给出普遍结论。

tesamorelin 是一种人工合成的四十四肽,序列与内源性生长激素释放激素(GHRH)的 1-44 片段一致,区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割,从而延长分子在循环中的存留时间。作为肽类分子,它难以经胃肠道吸收,文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物,以区别于生长激素本身。

Tesamorelin Identity And Structure

Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.

Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.

The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.

Tesamorelin at a glance

性质取值备注
分子类型合成四十四肽GHRH 类似物
N 端修饰反式-3-己烯酰基延缓酶切
分子量约 5135 Da依序列与修饰
受体靶点垂体 GHRH 受体经 cAMP 通路
常见同义名GHRH(1-44) 类似物文献通用称法

Molecular Background and Receptor Mechanism

Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.

Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.

Related pages on this site

Background and Receptor Mechanism

Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.

Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.

Background and Clinical Profile

Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.

After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.

Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.

Background from the literature

Specially, carbon nanotubes can be transformed into sophisticated biomolecule and allow its detection through changes in the carbon nanotube fluorescence spectra. Also, carbon nanotubes can be designed to match the size of small drug and endocitozed by a target cell, hence becoming a delivery agent.

==== Europe ==== In the European Union, Subutex and Suboxone, buprenorphine's high-dose sublingual tablet preparations, were approved for opioid use disorder treatment in September 2006. In the Netherlands, buprenorphine is a list II drug of the Opium Law, though special rules and guidelines apply to its prescription and dispensation. In France, buprenorphine prescription by general practitioners and dispensed by pharmacies has been permitted since the mid-1990s as a response to HIV and overdose risk. Deaths caused by heroin overdose were reduced by four-fifths between 1994 and 2002, and the incidence of AIDS among people who inject drugs in France fell from 25% in the mid-1990s to 6% in 2010.

Likewise, oral selegiline at an MAO-B-selective dosage did not appear to modify the pharmacodynamic effects or pharmacokinetics of intravenous methamphetamine in another study. Conversely, selegiline, also at MAO-B-selective doses, has been found to reduce the physiological and euphoric subjective effects of cocaine whilst not affecting its pharmacokinetics in some studies but not in others. Cautious safe combination of MAOIs like selegiline with stimulants like lisdexamfetamine has been reported. However, a hypertensive crisis with selegiline and ephedrine has also been reported. The selegiline drug labels warn about combination of selegiline with indirectly acting sympathomimetic agents, like amphetamines, ephedrine, pseudoephedrine, and phenylpropanolamine, due to the potential risk of hypertensive crisis, and recommend monitoring blood pressure with such combinations. The combination of selegiline with certain other medications, like phenylephrine and buspirone, is also warned against for similar reasons. In the case of phenylephrine, this drug is substantially metabolized by monoamine oxidase, including by both MAO-A and MAO-B. Selegiline can interact with exogenous dopamine, which is metabolized by MAO-A and MAO-B, and result in hypertensive crisis as well. Besides norepinephrine releasing agents, selective norepinephrine reuptake inhibitors (NRIs) may be safe in combination with MAOIs like selegiline. Potent NRIs, such as reboxetine, desipramine, protriptyline, and nortriptyline, can reduce or block the pressor effects of tyramine, including in those taking MAOIs.

When oxygen binds to the iron complex, it causes the iron atom to move back toward the center of the plane of the porphyrin ring (see moving diagram). At the same time, the imidazole side-chain of the histidine residue interacting at the other pole of the iron is pulled toward the porphyrin ring. This interaction forces the plane of the ring sideways toward the outside of the tetramer, and also induces a strain in the protein helix containing the histidine as it moves nearer to the iron atom. This strain is transmitted to the remaining three monomers in the tetramer, where it induces a similar conformational change in the other heme sites such that binding of oxygen to these sites becomes easier. As oxygen binds to one monomer of hemoglobin, the tetramer's conformation shifts from the T (tense) state to the R (relaxed) state. This shift promotes the binding of oxygen to the remaining three monomers' heme groups, thus saturating the hemoglobin molecule with oxygen. In the tetrameric form of normal adult hemoglobin, the binding of oxygen is, thus, a cooperative process. The binding affinity of hemoglobin for oxygen is increased by the oxygen saturation of the molecule, with the first molecules of oxygen bound influencing the shape of the binding sites for the next ones, in a way favorable for binding.

== Formation == Chondrocytes develop in the embryo from mesenchymal progenitor cells through a process known as chondrogenesis. A chondrocyte can then undergo mitosis to form an isogenous group within its lacuna.

Sources: en.wikipedia.org

Further detail

=== Filming === Filming began with the first round, which was shot through July 18–22, 2024, inside of Allegiant Stadium in Las Vegas, with a total of 2,000 contestants attending. This round is released on YouTube. The Beast City part of the competition that was featured in the first four, sixth, eighth and ninth episode of the TV series as well as a second YouTube video promoting the series featuring 20 eliminated contestants competing for $500,000, was filmed with the remaining 1,000 contestants at Downsview Park Studios in Toronto, Ontario, Canada, in August of that year. The "Beast Island" part of the competition featured in the fourth to sixth episodes, along with the tenth episode of the show was filmed at the uninhabited La Vivienda Island, which is located in the Pearl Islands, Panama. The filming broke 44 Guinness World Records, including the largest physical cash prize on set ($5,000,000), the most prize money turned down on a competitive reality TV show ($1,000,000), the largest prize fund awarded for a competitive reality TV show ($10,000,000), and the most money won in a single episode of a competitive reality TV show ($2,020,000), and a page in the 2026 Guinness Book of World Records was focused on the show.

Towards this end it sacrifices all, including the interests of the most revolutionary sections of the working class.” Here the CLP is referring to Lenin’s statement that the super-profits from the exploitation of the colonial peoples are used to bribe a sector of the working class in the imperialist country and turn this sector into an ally of the ruling class against the non-bribed sector of the working class. And further, "... the increasing economic crisis has forced the so-called "center” to the right and with it the CPUSA has moved to the right as well.”

=== Additional instar === Two populations of C. brunneus have females that have an additional instar inserted between instar II and III termed instar IIa. Morphological characteristics of instar IIa are a mixture of instars II and III. Females are of an intermediate size and length between instars II and III. Wing buds closely resemble the wing buds of instar II but have more venation than the typical wing buds of instar II. Genitalia development is closer to the development of instar III development. Additional instars have been found in other acridid species that display sexual dimorphism in which females are larger than males such as C. parallelus. C. brunneus females on average are 3 to 4 times larger than males. The occurrence of the additional instar most likely reflects the habitat the C. brunneus females occur. Females with the additional instar have only been found to occur in the region of East Anglia in Britain. The longer summers in East Anglia may facilitate earlier hatching and an increased growth rate permitting the inclusion of instar IIa allowing the females to reach a larger size. Decreased availability of food may encourage rapid development also explaining the inclusion of an additional instar.

Eastern countries such as China and Russia and most Muslim nations like Iran, Indonesia and Pakistan remained staunchly opposed." The outcome document recommended treatment, prevention and other public health measures, and committed to "intensifying our efforts to prevent and counter" drug production and trafficking, through, "inter alia, more effective drug-related crime prevention and law enforcement measures." A statement signed by 189 civil society organizations criticized the 2016 outcome document, itemizing the lack of progress and calling out the "highly problematic, non-inclusive and non-transparent" process that made it possible for "a handful of vocal and regressive countries [to] block progressive language", resulting in "an expensive restatement of previous agreements and conventions".

Sources: en.wikipedia.org

Supporting material

=== Global food distribution === Along with Archer Daniels Midland, Bunge, and Cargill, the Louis Dreyfus Company is one of the four "ABCD" companies that dominate world agricultural commodity trading.

An FSR is packed in a single trilaminate bag and contains filled pocket sandwiches, a pouch of tuna or chicken, two packets of ERGO high-energy drink mix, two high-energy First Strike Bars, a Soldier Fuel bar, two packets of beef jerky (BBQ or Teriyaki flavored), fortified applesauce, nut and fruit mix, caffeinated gum, and an accessory pack containing a beverage mix, salt, matches, tissues, plastic spoon, and cleansing moist towelettes. The FSR comes in three menus:

Hedonism about well-being, also called prudential hedonism, holds that pleasure and pain are the only factors of well-being. It states that how well a person's life goes depends entirely on how it feels to live it, expressed as the balance of pleasure over pain. According to this view, a person who experiences frequent joy and contentment has high well-being, whereas someone who is constantly in pain and suffering has low well-being. One view sees pleasure and pain as bodily sensations, like the pleasure of eating delicious food and the pain of injuring a leg. However, hedonists generally take a wider perspective, characterizing pleasure and pain broadly as any experience that feels good or bad. This broader understanding includes the intellectual pleasure of reading an engaging book and the sorrow of losing a loved one. According to quantitative hedonism, the value of each episode of pleasure and pain depends only on its intensity and duration. Qualitative hedonism, an alternative perspective, additionally considers non-quantitative factors, arguing that some pleasures are intrinsically superior to others because of their qualitative character, even if they have the same intensity and duration. One criticism of hedonism acknowledges that some pleasures have value but rejects that this is the case for all of them. According to this view, certain pleasures have no value and may even be bad for a person, such as sadistic pleasures from torturing animals.

Sources: en.wikipedia.org

Frequently asked questions

tesamorelin 与生长激素有什么区别?

tesamorelin 属 GHRH 类似物,作用于垂体受体以促进内源生长激素释放;生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。

它通常以何种方式进入体内?

作为多肽,它难以通过胃肠道吸收,通常需要注射给药。口服会因消化酶降解而失去活性,因此文献中讨论的都是注射途径。

目前研究主要关注哪些方向?

公开研究多集中在内脏脂肪、体成分分布以及与生长激素轴相关的代谢指标。长期安全性和在普通人群中的适用性尚缺乏一致结论。

Is tesamorelin the same as growth hormone?

No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.

Network